Bio
Martin Dieck is a Director in the Silicon Valley office since 2003. He is principally responsible for the Fund’s Life Sciences investments, and is for example involved with Intrapace, BodyMedia, Spinal Modulation, DirectFlow and holds a seat on the Board of Directors for Nfocus Neuromedical where he currently serves as their CEO. Building off of his experience in the development of therapies for the brain, he was able to step into Nfocus and focus their efforts on the development of next generation medical implants to treat brain aneurysms. Mr. Dieck co-founded and serves on the board of Leffect, inc., a company developing a system that is used to clear blood clots from the brains of stroke patients. Previously Mr. Dieck was Co-Founder, President and CEO of Concentric Medical, the first company to receive approval from the U.S. government to treat ischemic stroke, an affliction affecting over 750,000 people per year in the United States alone. Mr. Dieck also served as senior executive at a medical incubator where he evaluated early stage medical device opportunities and participated in the formation of four companies. Mr. Dieck was a co-founder of Micro Interventional Systems, a manufacturer of medical devices to pathologies in small blood vessels, which was acquired in 1996. In addition to his operational and deal flow evaluation expertise, Mr. Dieck is also an inventor with over 30 issued and pending patents. Mr. Dieck received his B.A. in Biological Sciences from Willamette University and M.B.A. from the University of California at Berkeley.
Career
|
ePlanet CapitalEmail: [email protected] |